| . | Carbapenem-Resistant Pathogensa . | ||||
|---|---|---|---|---|---|
| . | Stenotrophomonas maltophilia . | Acinetobacter baumannii . | Pseudomonas aeruginosa . | Klebsiella pneumoniae . | Proteus mirabilis . |
| Classification of infection, % | |||||
| Community-onset infection | 44.6 | 0 | 0.5 | 0.4 | 0 |
| Health care–associated infection | 6.6 | 40.4 | 42.5 | 44.3 | 73.9 |
| Hospital-acquired infection | 48.8 | 59.6 | 57.0 | 55.3 | 26.1 |
| Infection-associated length of stay, d | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Mean (SD) | 13.2 (19.8) | 12.9 (16.3) | 16.3 (22.6) | 15.0 (20.7) | 9.9 (8.9) |
| Median (min–max) | 9 (0–353) | 9 (1–143) | 10 (1–197) | 10 (1–187) | 7 (2–50) |
| Discharge status, % | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Discharge to home | 60.9 | 7.7 | 23.2 | 15.8 | 26.1 |
| Discharge to hospice | 2.3 | 2.1 | 6.3 | 10.7 | 6.1 |
| Discharge to other facilities (eg, skilled nursing facility) | 24.1 | 47.7 | 46.2 | 53.0 | 60.9 |
| In-hospital mortality | 12.8 | 47.7 | 24.3 | 20.6 | 7.0 |
| . | Carbapenem-Resistant Pathogensa . | ||||
|---|---|---|---|---|---|
| . | Stenotrophomonas maltophilia . | Acinetobacter baumannii . | Pseudomonas aeruginosa . | Klebsiella pneumoniae . | Proteus mirabilis . |
| Classification of infection, % | |||||
| Community-onset infection | 44.6 | 0 | 0.5 | 0.4 | 0 |
| Health care–associated infection | 6.6 | 40.4 | 42.5 | 44.3 | 73.9 |
| Hospital-acquired infection | 48.8 | 59.6 | 57.0 | 55.3 | 26.1 |
| Infection-associated length of stay, d | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Mean (SD) | 13.2 (19.8) | 12.9 (16.3) | 16.3 (22.6) | 15.0 (20.7) | 9.9 (8.9) |
| Median (min–max) | 9 (0–353) | 9 (1–143) | 10 (1–197) | 10 (1–187) | 7 (2–50) |
| Discharge status, % | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Discharge to home | 60.9 | 7.7 | 23.2 | 15.8 | 26.1 |
| Discharge to hospice | 2.3 | 2.1 | 6.3 | 10.7 | 6.1 |
| Discharge to other facilities (eg, skilled nursing facility) | 24.1 | 47.7 | 46.2 | 53.0 | 60.9 |
| In-hospital mortality | 12.8 | 47.7 | 24.3 | 20.6 | 7.0 |
Abbreviation: LOS, length of stay.
aPathogens were considered carbapenem-resistant if the interpretation for any carbapenem was listed as resistant or intermediate, excluding ertapenem for A. baumannii and P. aeruginosa.
| . | Carbapenem-Resistant Pathogensa . | ||||
|---|---|---|---|---|---|
| . | Stenotrophomonas maltophilia . | Acinetobacter baumannii . | Pseudomonas aeruginosa . | Klebsiella pneumoniae . | Proteus mirabilis . |
| Classification of infection, % | |||||
| Community-onset infection | 44.6 | 0 | 0.5 | 0.4 | 0 |
| Health care–associated infection | 6.6 | 40.4 | 42.5 | 44.3 | 73.9 |
| Hospital-acquired infection | 48.8 | 59.6 | 57.0 | 55.3 | 26.1 |
| Infection-associated length of stay, d | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Mean (SD) | 13.2 (19.8) | 12.9 (16.3) | 16.3 (22.6) | 15.0 (20.7) | 9.9 (8.9) |
| Median (min–max) | 9 (0–353) | 9 (1–143) | 10 (1–197) | 10 (1–187) | 7 (2–50) |
| Discharge status, % | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Discharge to home | 60.9 | 7.7 | 23.2 | 15.8 | 26.1 |
| Discharge to hospice | 2.3 | 2.1 | 6.3 | 10.7 | 6.1 |
| Discharge to other facilities (eg, skilled nursing facility) | 24.1 | 47.7 | 46.2 | 53.0 | 60.9 |
| In-hospital mortality | 12.8 | 47.7 | 24.3 | 20.6 | 7.0 |
| . | Carbapenem-Resistant Pathogensa . | ||||
|---|---|---|---|---|---|
| . | Stenotrophomonas maltophilia . | Acinetobacter baumannii . | Pseudomonas aeruginosa . | Klebsiella pneumoniae . | Proteus mirabilis . |
| Classification of infection, % | |||||
| Community-onset infection | 44.6 | 0 | 0.5 | 0.4 | 0 |
| Health care–associated infection | 6.6 | 40.4 | 42.5 | 44.3 | 73.9 |
| Hospital-acquired infection | 48.8 | 59.6 | 57.0 | 55.3 | 26.1 |
| Infection-associated length of stay, d | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Mean (SD) | 13.2 (19.8) | 12.9 (16.3) | 16.3 (22.6) | 15.0 (20.7) | 9.9 (8.9) |
| Median (min–max) | 9 (0–353) | 9 (1–143) | 10 (1–197) | 10 (1–187) | 7 (2–50) |
| Discharge status, % | |||||
| No. | 486 | 235 | 379 | 253 | 115 |
| Discharge to home | 60.9 | 7.7 | 23.2 | 15.8 | 26.1 |
| Discharge to hospice | 2.3 | 2.1 | 6.3 | 10.7 | 6.1 |
| Discharge to other facilities (eg, skilled nursing facility) | 24.1 | 47.7 | 46.2 | 53.0 | 60.9 |
| In-hospital mortality | 12.8 | 47.7 | 24.3 | 20.6 | 7.0 |
Abbreviation: LOS, length of stay.
aPathogens were considered carbapenem-resistant if the interpretation for any carbapenem was listed as resistant or intermediate, excluding ertapenem for A. baumannii and P. aeruginosa.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
